TheraVet, a pioneer in biotechnology in the treatment of osteoarticular diseases in pets, today announces the signing of an exclusive distribution agreement with Invictos Orthopedics LLC, a North American company that designs, develops and markets orthopedic and veterinary medical devices.
Harold Wotton, founder and CEO of Invictos Orthopedics, says, “The addition of the TheraVet product line represents an important milestone for our orthopedic product portfolio. TheraVet products are a perfect fit into our growing orthopedic surgery offering and we are delighted to make this innovation available in veterinary orthopedics. “
Enrico Bastianelli, managing director of TheraVet, comments: “The signing of a distribution agreement with such a specialized company is an essential step in achieving the commercial objectives that TheraVet has set itself in the United States. We are delighted to start this collaboration and to take advantage of Dr. Wotton’s unique experience in the American veterinary orthopedic market, a decisive advantage for the promotion of BIOCERA-VET. “
–